NCT01716962

Brief Summary

Fluid responsiveness (FR)refers to the ability of heart to increase its stroke volume in response to volume load.Low tidal volume and high PEEP exerts contrast effect on the prediction of fluid responsiveness, the aim of this study is to compare the relative predicting power of the dynamic preload indicator (PPV, SVV), passive leg raising test, and pleth variability index (PVI) on the fluid responsiveness of acute respiratory distress syndrome ventilated with various PEEP levels or various tidal volumes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2012

Completed
2 days until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Last Updated

December 3, 2012

Status Verified

November 1, 2012

Enrollment Period

1.7 years

First QC Date

October 26, 2012

Last Update Submit

November 30, 2012

Conditions

Keywords

Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variationPleth variability index, Passive leg raising test

Outcome Measures

Primary Outcomes (1)

  • increase of cardiac output after volume expansion

    Patients are classified to be volume expansion responders or nonresponders according to whether the volume expansion induced cardiac index increase at the end of hydroxyethyl starch infusion is ≧15% or \< 15% of baseline cardiac index.

    4 hours

Study Arms (1)

ARDS with acute circulatory failure

acute respiratory distress syndrome with acute circulatory failure with infusion of 6% tetrastarch for a total of 500ml

Other: Infusion of 6% tetrastarch for a total of 500 ml

Interventions

ARDS with acute circulatory failure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

mechanically ventilated ALL/ARDS patients conforming to the American European Consensus Conference criteria with acute circulatory failure for whom the attending clinician had decided to administer fluid will be enrolled.This decision was based on the presence of at least one clinical sign of inadequate tissue perfusion in the absence of contraindication for fluid infusion.

You may qualify if:

  • systolic blood pressure\< 9 mmHg(or a decrease \> 50 mmHg in previously hypertensive patients)
  • need of vasopressive drugs(dopamine \> 5 ug/Kg/min or norepinephrine)
  • urine output\<0.5 mL/Kg/hr for at least 2 hrs
  • tachycardia (heart rate \>100/min)
  • presence of skin mottling.

You may not qualify if:

  • patient with spontaneous respiratory activity
  • cardiac arrhythmia
  • known intracardiac shunt
  • contraindication for passive leg raising(PLR),e.g.,pelvic trauma
  • unstable spine injuries or leg amputation
  • hemodynamic instability during the procedure,defined by a variation in heart rate or blood pressure of\>10%over the 15-min period before starting the protocol
  • Patients of renal failure necessitate renal replacement therapy will be excluded also.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taipei, Taiwan, 10507, Taiwan

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Chung-Chi Huang, MD

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department of Respiratory Therapy, Chang Gung University

Study Record Dates

First Submitted

October 26, 2012

First Posted

October 30, 2012

Study Start

November 1, 2012

Primary Completion

July 1, 2014

Last Updated

December 3, 2012

Record last verified: 2012-11

Locations